Work

Pimavanserin - a potential first line therapy for Parkinson's disease psychosis

Year: 2009

Type: article

Authors: Uli Hacksell, Krista McFarland, Hilde Williams, D BONHAUS, Roger Mills

Institution: Acadia Pharmaceuticals (United States)

Language: English

Topic: Parkinson's Disease Mechanisms and Treatments

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W45020151

FWCI:

Cites:

Cited by:

Related to: 10